Sientra reported 12.84M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abiomed ABMD:US $ 218.39M 4.84M
Align Technology ALGN:US $ 709.35M 35.22M
Cerus CERS:US $ 24.94M 5.67M
Cooper Companies COO:US $ 532.5M 14.1M
Dexcom DXCM:US $ 398.1M 102.6M
Globus Medical GMED:US $ 171.38M 16.84M
Insulet PODD:US $ 209.7M 3.5M
Integra Lifesciences IART:US $ 238.6M 16.25M
Johnson & Johnson JNJ:US $ 15828M 1021M
Nuvasive NUVA:US $ 211.66M 6.88M
Orasure Technologies OSUR:US $ 24.27M 2.86M
Sientra SIEN:US 12.84M 518K
Staar Surgical STAA:US $ 49.26M 4.27M
Stryker SYK:US $ 2727M 272M
Teleflex TFX:US $ 346.23M 73.5M
Utah Medical Products UTMD:US 8.07M 1.13M
Zimmer Biomet Holdings Inc ZBH:US $ 1.16B 213.2M